Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Jefferies Cuts Price Target on Marine Bio (MBII) Following a Light 1Q
May 17, 2016 8:11 AM EDTJefferies maintained a Hold rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $0.75 (from $1.00), following the company's 1Q earnings report. MBII reported a loss of $0.38, $0.13 worse than consensus. Sales rose 30%, with a 79% increase in product shipments.
Analyst Laurence... More
